Victory Capital Management Inc Novavax Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Novavax Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 19,292 shares of NVAX stock, worth $177,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,292

Previous 17,220 12.03%

Holding current value

$177,100

Previous $218,000 11.47%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$10.71 - $17.11 $22,191 - $35,451	2,072 Added 12.03%	19,292 $243,000
Q2 2024 Aug 05, 2024	SELL	$3.89 - $20.97 $497 - $2,684	-128 Reduced 0.74%	17,220 $218,000
Q1 2024 May 03, 2024	BUY	$3.76 - $6.02 $8,486 - $13,587	2,257 Added 14.96%	17,348 $82,000
Q4 2023 Feb 05, 2024	BUY	$4.8 - $7.67 $72,436 - $115,747	15,091 New	15,091 $72,000
Q2 2022 Aug 01, 2022	SELL	$36.28 - $75.29 $269,016 - $558,275	-7,415 Reduced 41.81%	10,319 $531,000
Q1 2022 May 04, 2022	SELL	$69.73 - $142.9 $1.15 Million - $2.36 Million	-16,505 Reduced 48.21%	17,734 $799,000
Q4 2021 Feb 07, 2022	SELL	$134.56 - $217.97 $123,660 - $200,314	-919 Reduced 2.61%	34,239 $4.9 Million
Q3 2021 Nov 02, 2021	SELL	$177.8 - $270.58 $4.65 Million - $7.08 Million	-26,167 Reduced 42.67%	35,158 $7.29 Million
Q2 2021 Aug 03, 2021	BUY	$121.0 - $257.67 $1.31 Million - $2.78 Million	10,799 Added 21.37%	61,325 $13 Million
Q1 2021 May 04, 2021	BUY	$112.98 - $319.93 $3.39 Million - $9.59 Million	29,970 Added 145.8%	50,526 $9.16 Million
Q4 2020 Feb 01, 2021	BUY	$78.74 - $139.5 $207,716 - $368,001	2,638 Added 14.72%	20,556 $2.29 Million
Q3 2020 Nov 09, 2020	SELL	$79.44 - $178.51 $1.09 Million - $2.45 Million	-13,715 Reduced 43.36%	17,918 $1.94 Million
Q2 2020 Aug 07, 2020	BUY	$13.86 - $83.61 $319,861 - $1.93 Million	23,078 Added 269.76%	31,633 $2.64 Million
Q1 2020 May 04, 2020	BUY	$3.93 - $16.0 $12,375 - $50,384	3,149 Added 58.25%	8,555 $116,000
Q4 2019 Feb 04, 2020	BUY	$3.69 - $5.22 $5,287 - $7,480	1,433 Added 36.07%	5,406 $41,000
Q3 2019 Nov 12, 2019	BUY	$4.02 - $7.84 $15,971 - $31,148	3,973 New	3,973 $20,000

Others Institutions Holding NVAX

# of Institutions

286

Shares Held

84.7M

Call Options Held

5.38M

Put Options Held

8.62M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Novavax Inc Transaction History